sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 551-575 out of 1309.

<< < 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 > >>

Public Release: 2-Mar-2016
Quarterly Journal of Economics
Why pharmaceutical firms may prefer to invest in drugs over vaccines
When it comes to addressing disease, many industry observers and public health advocates believe that pharmaceutical companies prefer to invest in drugs rather than vaccines, as preventives are perceived to be inherently less profitable. A Harvard-Dartmouth study on preventives versus treatments recently summarized in 'VOX EU,' offers a new economic rationale for this trend -- the population risk for diseases resembles a Zipf distribution, where the demand curve for a drug is likely to support stronger revenue extraction from a drug than for a vaccine.

Contact: Amy Olson
Dartmouth College

Public Release: 2-Mar-2016
JAMA Cardiology
Study examines prevalence of rheumatic heart disease in developing country
Thomas Pilgrim, M.D., of Bern University Hospital, Bern, Switzerland, and colleagues conducted a study to determine the prevalence and incidence of clinically silent and manifest rheumatic heart disease in Eastern Nepal. The study was published online by JAMA Cardiology.

Contact: Thomas Pilgrim, M.D.
The JAMA Network Journals

Public Release: 2-Mar-2016
TSRI scientists find clues to neutralizing coronaviruses such as MERS
Scientists at the Scripps Research Institute, Dartmouth and the National Institutes of Health have solved the structure of a key protein in HKU1, a coronavirus identified in Hong Kong in 2005 and highly related to SARS and MERS. They believe their findings will guide future treatments for this family of viruses.
NIH/National Institute of Allergy and Infectious Diseases, Scripps Research Institute, Geisel School of Medicine at Dartmouth, National Institutes of Health

Contact: Madeline McCurry-Schmidt
Scripps Research Institute

Public Release: 2-Mar-2016
PLOS Biology
How to prevent 10 million deaths a year
Strategic investments to discover and develop new health tools, together with innovations in effectively delivering today's health tools and services, could avert 10 million deaths a year within just one generation, argue leading global health experts in a new PLOS Collection.

Contact: Jennifer Horsely

Public Release: 1-Mar-2016
JAMA Pediatrics
Children's Hospital Colorado experts publish article on the 2014 enterovirus D68 outbreak
From August to September 2014, a nationwide outbreak of enterovirus D68 (EV-D68) left resources constrained for Children's Hospital Colorado (Children's Colorado) and pediatric organizations throughout the nation. Researchers and operational experts at Children's Colorado looked at the change in hospital resources utilized during the outbreak periods and compared the data to what would have been expected during a calm respiratory season, which allowed the team to indirectly estimate the impact of the virus.
NIH/National Center for Advancing Translational Sciences

Contact: Hollon Kohtz
Children's Hospital Colorado

Public Release: 1-Mar-2016
Annals of Global Health
Experts assess the impact of climate change on public health
In a review published in the Annals of Global Health, doctors warn of the impending public health crisis brought on by climate change and call for action to help prepare the world for what is ahead.

Contact: Eileen Leahy
Elsevier Health Sciences

Public Release: 29-Feb-2016
Journal of Global Health
Free ambulance service halves pregnancy-related deaths in rural Ethiopia
An operational assessment of a national free ambulance services program reveals a drastic reduction in pregnancy-related deaths in rural Ethiopia, suggesting that the innovative model could offer a cost-effective way to improve maternal health outcomes across Sub-Saharan Africa. This argument is presented in an article published today in the Journal of Global Health.

Contact: Daniel Harju
Umea University

Public Release: 29-Feb-2016
Anti-bacterial fabric holds promise for fighting superbug
An industry-academic collaborative group, involving UNIST, Yeejoo Co., Ltd., and KICET developed an anti-bacterial fabric, using a natural bacterial pigment.
Korea Institute for Advancement of Technology

Contact: JooHyeon Heo
Ulsan National Institute of Science and Technology(UNIST)

Public Release: 29-Feb-2016
PLOS Neglected Tropical Diseases
Risk of catching Ebola from survivor 'very low'
New research finds the risk of catching Ebola from a survivor to be 'very low.' Researchers set out to discover how long the Ebola virus persists in different human body fluids -- including blood, urine, semen, sweat, breast milk, feces, and vaginal fluids. While other health complications have been widely reported, the team did not find any evidence that the virus can reactivate to the point it becomes infectious for others by non-sexual contact.
National Institute for Health Research Health Protection Research Unit on Emergency Preparedness and Response

Contact: Lisa Horton
University of East Anglia

Public Release: 29-Feb-2016
New vaccine could save thousands of lives
Work led by University of Exeter experts could help to protect thousands of people from an often fatal disease found in most tropical regions.
Fondazione CARIPLO

Contact: Kerra Maddern
University of Exeter

Public Release: 29-Feb-2016
Bulletin of the World Health Organization
People in world's poorest countries missing out on surgery
The volume of surgery has increased globally over the last decade but wide disparities in access to surgery persist between rich and poor countries. Only about 30 percent of the 312.9 million operations performed in 2012 were done in the 104 countries that spend less than US$400 on health care per capita per year, according to a study published today in the Bulletin of the World Health Organization.

Contact: Fiona Fleck
Bulletin of the World Health Organization

Public Release: 26-Feb-2016
Electron microscopy captures snapshot of structure coronaviruses use to enter cells
A detailed analysis has been made, at the atomic level, of an infection mechanism of coronaviruses, the agents of both mild and deadly respiratory illness in people and animals. The model of the coronavirus spike protein, which promotes entry into cells, may inspire design of antibodies to block a variety of coronaviruses. It also offers clues about the animal species or cell types a coronavirus is primed to attack.
NIH/National Institute of General Medical Sciences at National Institutes of Health, National Resource for Automated Molecular Microscopy

Contact: Leila Gray
University of Washington Health Sciences/UW Medicine

Public Release: 26-Feb-2016
Optometry and Vision Science
108 million people have correctable vision impairment, global study estimates
Uncorrected refractive error -- nearsightedness, farsightedness, and other focusing problems correctable by prescription lenses -- is responsible for moderate to severe vision impairment in 101 million people and blindness in seven million people worldwide, reports a study in the March issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

Contact: Connie Hughes
Wolters Kluwer Health

Public Release: 26-Feb-2016
Parasites & Vectors
Insecticide-treated nets may still prevent malaria despite mosquito resistance
Insecticide-treated nets may still help prevent malaria despite mosquitoes developing resistance, which may provide a clue to why it has been hard to demonstrate the impact of this resistance on malaria as a public health problem, according to new research by the London School of Hygiene & Tropical Medicine and Malaria Consortium.
UK Aid

Contact: Jenny Orton
London School of Hygiene & Tropical Medicine

Public Release: 26-Feb-2016
BMJ Global Health
Study finds 36 percent increase in number of male smokers in India
The number of men smoking tobacco in India rose by more than one-third to 108 million between 1998 and 2015, according to a new study published today in the journal BMJ Global Health.

Contact: Leslie Shepherd
St. Michael's Hospital

Public Release: 25-Feb-2016
Single antibody from human survivor protects nonhuman primates against Ebola virus
A single monoclonal antibody isolated from a human survivor of Ebola virus disease (EVD) completely protected monkeys from lethal infection with the virus, according to research published in today's online edition of the journal Science. Importantly, the antibody, known as mAb114, was effective even when given five days after exposure to Ebola virus, suggesting that it could hold promise as a potential treatment for human cases of EVD.
Intramural Research Program of the Vaccine Research Center, NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 25-Feb-2016
Emerging Infectious Diseases
Post-Ebola syndrome in Sierra Leone
Researchers from the University's Institute of Translational Medicine have conducted a study of Ebola survivors to describe the medical problems they continue to have after recovering from the acute disease. The results of which have been published in the journal Emerging Infectious Diseases.

Contact: Simon Wood
University of Liverpool

Public Release: 25-Feb-2016
Trends in Parasitology
Zeroing in on 'super spreaders' and other hidden patterns of epidemics
The complex properties driving today's disease transmission -- and the speed at which an epidemic can travel -- call for new methods of surveillance. Researchers propose a novel way of developing mathematical models of infectious diseases to uncover hidden patterns of transmission.

Contact: Carol Clark
Emory Health Sciences

Public Release: 25-Feb-2016
Experimental Ebola antibody protects monkeys
NIAID scientists and colleagues have discovered that a single monoclonal antibody isolated from a human Ebola virus disease survivor protected non-human primates when given as late as five days after lethal Ebola infection. The antibody can now advance to testing in humans as a potential treatment for Ebola virus disease. There are currently no licensed treatments for Ebola infection, which caused more than 11,000 deaths in the 2014-2015 outbreak in West Africa.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 25-Feb-2016
Water-cleaning chemical made 'on-demand' with new group of catalysts
A quick, cheap and highly efficient method for producing a water-purifying chemical has been developed by researchers at Cardiff University.

Contact: Michael Bishop
Cardiff University

Public Release: 25-Feb-2016
PLOS Neglected Tropical Diseases
Zika virus linked to stillbirth, other symptoms in Brazil
In January, a pregnant Brazilian woman infected with the Zika virus had a stillborn baby who had signs of severe tissue swelling as well as central nervous system defects that caused near-complete loss of brain tissue. It is the first report to indicate a possible association of congenital Zika virus and damage to tissues outside the central nervous system, said Yale researchers.

Contact: Michael Greenwood
Yale University

Public Release: 25-Feb-2016
PLOS Pathogens
Nitric oxide protects against parasite invasion and brain inflammation by keeping the blood brain barrier intact
African trypanosomiasis is called 'sleeping sickness' because when the infection is untreated, trypanosome parasites will invade the brain and cause disruption of sleeping patterns and irreversible neurological damage. A study published on Feb. 25 in PLOS Pathogens reports that in a mouse model of trypanosome disease, nitric oxide plays an unexpected role in preserving the integrity of the blood brain barrier, thereby reducing parasite invasion into the brain, and likely limiting neurological damage.

Contact: Martin Rottenberg

Public Release: 24-Feb-2016
Human Gene Therapy
Update on advances in gene therapy From National Center for Advancing Translational Sciences
New initiatives by the National Center for Advancing Translational Sciences (NCATS) to use gene therapy approaches to treat rare diseases and especially promising aspects of gene transfer and gene editing technology, such as adeno-associated viral (AAV) vectors and CRISPR-Cas9 are highlighted in an editorial published in Human Gene Therapy.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 24-Feb-2016
2016 68th AAN Annual Meeting
Most Ebola survivors in study experienced brain symptoms 6 months after infection
Most of the 82 Ebola survivors in a new study from the world's largest Ebola outbreak had brain symptoms more than six months after the initial infection. The preliminary results will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016. The study is part of the larger Prevail III study, which follows patients with prior Ebola virus disease and their close contacts who serve as study controls.

Contact: Rachel Seroka
American Academy of Neurology

Public Release: 23-Feb-2016
2016 Conference on Retroviruses and Opportunistic Infections
Study: Experimental Ebola drug ZMapp may benefit patients, but insufficient data
According to initial results from a randomized, controlled trial of the experimental Ebola treatment ZMapp, the monoclonal antibody cocktail was well-tolerated and showed promise. Due to decreasing incidence in Ebola, the study could not enroll enough volunteers to determine definitively whether it is a better treatment for Ebola virus disease than supportive care only. Initial findings from the clinical trial known as PREVAIL II were presented today at the Conference on Retroviruses and Opportunistic Infections in Boston.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
NIH/National Institute of Allergy and Infectious Diseases

Showing releases 551-575 out of 1309.

<< < 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 > >>